Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.
Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen for urinary tract infections (UTIs), at the Royal Hospital ...
Ad-hoc-Mitteilung gemäss Art. 53 KRBasel, 22. Oktober 2026 Roche setzt starke Dynamik im dritten Quartal mit Umsatzwachstum von +7% zu konstanten Wechselkursen (CER) und +8% in CHF fort; Konzernverkäu ...